Back to Search
Start Over
MICRObiota on BILIOpancreatic malignant diseases [MICROBILIO]: A systematic review
- Source :
- Clinics; January-December 2022, Vol. 77 Issue: 1
- Publication Year :
- 2022
-
Abstract
- •Microbial agents and their metabolites are being tested to develop treatments that can reduce the tumor and are potentially preventable.•Microbiota is observed in all clinical and pathological stages of carcinogenesis, from its development, diagnosis, and treatment, including prognosis and survival.•There is a lack of studies on biliary microbiota and its relationship with hepatobiliopancreatic diseases.
Details
- Language :
- English
- ISSN :
- 18075932 and 19805322
- Volume :
- 77
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Clinics
- Publication Type :
- Periodical
- Accession number :
- ejs61372045
- Full Text :
- https://doi.org/10.1016/j.clinsp.2022.100101